Literature DB >> 821601

Human intestinal goblet cell mucin.

I Jabbal, D I Kells, G Forstner, J Forstner.   

Abstract

Goblet cell mucin (GCM) has been purified for the first time from mucosal scrapings of human small intestine. Proteolytic enzymes and organic solvents were avoided during the isolation procedure. The mucin was purified by Sepharose 4B and 2B column chromatography of high-speed supernatant fractions. The most purified fraction was compared with rat intestinal GCM. The two were similar with respect to chemical composition, antigenic features, and polyacrylamide disc gel electrophoresis. The major chemical differences included a higher hexosamine-fucose and hexosamine-sialic acid ratio in human mucin. The two mucins showed strong concentration dependence in sedimentation velocity studies. Human mucin at a concentration of 0.2 to 1.5 mg protein per millilitre gave multiple associated peaks with variable So values (10.8-36.6). Rat mucin, in contrast, gave a constant (although polydisperse) pattern with So = 15.15. To explore these differences both mucins were stained with periodic acid - Schiff reagent and subjected to band ultracentrifugation at concentrations of 0.6-1.9 mug protein per millilitre. At this low concentration, rat mucin did not change in its sedimentation characteristics. In contrast, human GCM produced a single peak with So = 37.9. Thus dilution abolished polydispersity in the human but not the rat mucin, suggesting that intermolecular bonding forces in the human mucin are weaker.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821601     DOI: 10.1139/o76-102

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  23 in total

1.  Development of anti-human colonic mucin monoclonal antibodies. Characterization of multiple colonic mucin species.

Authors:  D K Podolsky; D A Fournier; K E Lynch
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

2.  Purification of rat intestinal maltase/glucoamylase and its anomalous dissociation either by heat or by low pH.

Authors:  P R Flanagan; G G Forstner
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

3.  Enhancement of the viscosity of mucin by serum albumin.

Authors:  S J List; B P Findlay; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

4.  Purification and characterization of goblet-cell mucin of high Mr from the small intestine of sheep.

Authors:  T K Mukkur; D L Watson; K S Saini; A K Lascelles
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

5.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Authors:  A R Colina; F Aumont; N Deslauriers; P Belhumeur; L de Repentigny
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  In vitro synthesis and secretion of glycoprotein by human mammary tissue.

Authors:  G B Dermer; Z A Tökés
Journal:  In Vitro       Date:  1978-09

7.  Effect of long generation times on growth of Bacteroides thetaiotaomicron in carbohydrate-induced continuous culture.

Authors:  S F Kotarski; A A Salyers
Journal:  J Bacteriol       Date:  1981-06       Impact factor: 3.490

8.  Modulation of proline-rich protein biosynthesis in rat parotid glands by sorghums with high tannin levels.

Authors:  H Mehansho; A Hagerman; S Clements; L Butler; J Rogler; D M Carlson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Glycoprotein degradation in the blind loop syndrome: identification of glycosidases in jejunal contents.

Authors:  R Prizont
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

10.  Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes.

Authors:  L C Hoskins; E T Boulding
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.